| Abstract: |
A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. |
| Inventor: |
EPNER, PAUL (San Diego, CA, US); ZIMMER, III, RICHARD (Mandeville, LA, US); MASSEY, BILL W. (Heber Springs, AR, US) |
| Applicant: |
ENGEN MEDICAL CORPORATION (San Diego, CA, US) |
| Face Assignee: |
N/A |
| Filed: |
2018-01-05 |
| Issued: |
2018-07-12 |
| Claims: |
7 |
|
US20180193395
|
1. A composition of Panax quinquefolius comprising a dosage in an amount effective for the attenuation of Cannabis-induced dysphoria.
(1)
(0)
|
|
5. A method for the attenuation of Cannabis-induced dysphoria comprising administering a therapeutically effective amount of a composition containing Panax quinquefolius where the amount of Panax quinquefolius is 300 mg.
(1)
(0)
|
|
